Fu; Qinghong

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fu; Qinghong.The latest application filed is for "bicyclic heteroaryl substituted compounds".

Company Profile

3.13.12

Fu; Qinghong - Plainsboro NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bicyclic heteroaryl substituted compounds Grant 10,730,868 - Fu , et al.	2020-08-04
Inhibitors of the renal outer medullary potassium channel Grant 10,513,518 - deJesus , et al. Dec	2019-12-24
Bicyclic Heteroaryl Substituted Compounds App 20190300520 - Fu; Qinghong ; et al.	2019-10-03
Inhibitors of the renal outer medullary potassium channel Grant 9,951,052 - Pasternak , et al. April 24, 2	2018-04-24
Inhibitors Of The Renal Outer Medullary Potassium Channel App 20180009807 - deJesus; Reynalda K. ; et al.	2018-01-11
Inhibitors of the renal outer medullary potassium channel Grant 9,850,245 - Pasternak , et al. December 26, 2	2017-12-26
Inhibitors of the renal outer medullary potassium channel Grant 9,839,629 - Dong , et al. December 12, 2	2017-12-12
Inhibitors Of The Renal Outer Medullary Potassium Channel App 20170275283 - Pasternak; Alexander ; et al.	2017-09-28
Inhibitors Of The Renal Outer Medullary Potassium Channel App 20170275298 - Pasternak; Alexander ; et al.	2017-09-28
Inhibitors of the renal outer medullary potassium channel Grant 9,527,830 - Walsh , et al. December 27, 2	2016-12-27
Inhibitors Of The Renal Outer Medullary Potassium Channel App 20160324833 - Dong; Shuzhi ; et al.	2016-11-10
Inhibitors of the Renal Outer Medullary Potassium Channel App 20160257670 - Pasternak; Alexander ; et al.	2016-09-08
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Grant 8,809,579 - Kats-Kagan , et al. August 19, 2	2014-08-19
Aryl pyridines and methods of their use Grant 8,153,804 - Augeri , et al. April 10, 2	2012-04-10
4-amino-1H-pyrimidin-2-one based compounds, compositions comprising them and methods of their use Grant 8,093,245 - Augeri , et al. January 10, 2	2012-01-10
O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer Grant 8,093,246 - Augeri , et al. January 10, 2	2012-01-10
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use App 20110312911 - Kats-Kagan; Roman ; et al.	2011-12-22
4-amino-1h-pyrimidin-2-one Based Compounds, Compositions Comprising Them And Methods Of Their Use App 20080182847 - Augeri; David J. ; et al.	2008-07-31
O-linked Pyrimidin-4-amine-based Compounds, Compositions Comprising Them, And Methods Of Their Use To Treat Cancer App 20080146571 - Augeri; David J. ; et al.	2008-06-19
Aryl pyridines and methods of their use App 20070032501 - Augeri; David J. ; et al.	2007-02-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.